home | about us | general info | AGENDA | social program | registration | contact us | excursion | sponsors | links     hrvatski

Main topics:

Epidemiology od CHD and cerebrovascular disease
Dyslipidemias in adults and children and their treatment
Family hypercholesterolaemia
Diabetes, obesity and metabolic syndrome
Hypertension
Diet and atherosclerosis risk
Lifestyle and CHD
Angiography, CAT and MR in the assessment of atherosclerosis
Nuclear cardiology
Percutaneous angioplasty, stents etc.
Antiagregation and thrombolytic therapy
Surgery for atherosclerosis of coronary and peripheral arteries
Atherosclerosis and cerebrovascular disorders

Timetable:

THURSDAY
May 16th
FRIDAY
May 17th
SATURDAY
May 18th
  09:30 – 11:00
PLENARY SESSION
 9:30 – 11:30 PLENARY SESSION
– 14:00
ARRIVAL
11:00 – 11:45
COFFEE,
POSTERS
AND EXHIBITION
11:30 – 11:45
YOUNG INVESTIGATOR
AWARD CEREMONY
– 15:00
REGISTRATION
11:45 – 13:15
PLENARY SESSION
 11:45 – 12:00
CLOSING OF THE CONGRESS
16:00 – 16:30
OPENING CEREMONY
13:15 – 14:15
CAS BUISNESS MEETING
 
16:30  – 19:00
PLENARY SESSION
14:15  – 15:30
LUNCH
 
20:00 –
DINNER
 15:30 – 16:30
PLENARY SESSION
 
  16:30 – 17:00
COFFEE,
POSTERS
AND EXHIBITION
 
  17:00 – 18:30
PLENARY SESSION
 
  20:30 –
GALA
DINNER
 

Plenary lectures:

INVITED SPEAKERS

Prof. Ian Graham – From LDL to lifetime risk estimation: can we see the future?

Prof Richard Češka – ScreenPro FH: An example of international cooperation in preventive Cardiology

Prof. Lale Tokozoglu – Imaging atherosclerotic vascular disease for risk prediction

Prof. Alberto Zambon – Will precision medicine help tailor dyslipidaemia treatment?

Prof. Marat Ezhow – Lipoprotein(a) as the sword of Damocles of our time

Prof. Michal Vrablik – New paradigms in clinical lipidology

Prof. Alexandros Tselepis – Lp(a): Causality for ASCVD and emerging therapies

Prof. Kornelia Kotseva – Use of lipid-modifying therapy and LDL-C goal attainment in high and very high cardiovascular risk patients: Real world evidence from 27 countries in Europe

Prof. Maciej Banach – ILEP 2019 recommendations on lipid-lowering therapy during pregnancy

Prof Josef Marek – Early cardiac signs and symptoms of Fabry disease cardiology and stroke diagnosis

Prof.Zlatko Fras – Integration of primary and secondary cardiovascular prevention - crossing paths and implementation feasibility

Prof. Željko Reiner – PCSK9 inhibitors past, present and future

Prof.Luka Zaputović – How to improve prevention of cardiovascular diseases in Croatia

Prof. Iveta Merćep – Statin side effects - myth or reality?

Ass.Prof.Ranko Stevanović – TBA

Prof.Jadranka Sertić – Genetic markers of atherosclerosis and stroke

Prof.Fran Borovečki – Genome diagnostics of Familial Hypercholesterolemia

Prof.Diana Muačević-Katanec – Hs-CRP and acute coronary syndrome

Nediljko Šućur – Uric acid as an independent risk factor for cardiovascular disease

Prof.Davor Miličić – Treatment of dyslipidaemia in ACS

Ass.Prof.Ivan Pećin – FH and ACS: what went wrong?

Mag.Eva Pavić – Diet in cardiovascular diseases - truth and controversy

Prof.Mijo Bergovac – Cardiology in the next 10 years - desires and perspectives

Maja Baretić – Cardiovascular outcomes trials in type 2 diabetes; benefit beyond glycaemic regulation

Prof.Vida Demarin – Stroke prevention - focus on lifestyle modification

Prof.Jelaković Bojan – Controversy in hypertension in 2019


Poster topics:

To be announced.